Tumor thickness is associated with metastasis in patients with submucosal invasive adenocarcinoma of the esophagogastric junction
In submucosal invasive adenocarcinoma of the esophagogastric junction (pT1b-SM AEG), the extent of tumor submucosal (SM) invasion is measured using the vertical depth of SM invasion with the muscularis mucosa. This study aimed to investigate whether tumor thickness and depth of invasion without accounting for muscularis mucosa were superior to the vertical depth of SM invasion as metastasis predictors. We enrolled patients with pT1b-SM AEG who underwent endoscopic resection or surgical resection (SR) at our institution between January 2011 and September 2019 and were followed up for ≥2 years. The relationship between metastasis and clinicopathological factors was examined. Metastasis was defined as pathologically confirmed lymph node metastasis in the surgical specimen or recurrence during follow-up. This study included 57 patients (44 men; median age, 72 years). Endoscopic resection and SR were performed in 16 and 41 patients, respectively. Nine patients were diagnosed with metastasis: five who underwent SR showed pathologically confirmed lymph node metastasis in the surgical specimens, and four experienced recurrences during a median follow-up of 48 months. Univariate analyses showed that tumor thickness was significantly associated with metastasis (P = 0.021), and the vertical depth of SM invasion (P = 0.48) and depth of invasion (P = 0.38) were not. Furthermore, in multivariate analysis, tumor thickness ≥2800 μm (odds ratio, 38.70; P = 0.013) was a significant predictor for metastasis. Tumor thickness may be a more convenient and useful predictor of metastasis in patients with pT1b-SM AEG than the vertical depth of SM invasion.
Authors
- Takahiro Kinoshita (ORCID: https://orcid.org/0000-0001-7365-8733)
- Tatsuro Murano (ORCID: https://orcid.org/0000-0003-0423-2151)
- Hiroaki Ikematsu (ORCID: https://orcid.org/0000-0001-9840-4588)
- Takeo Fujita
- Keiichiro Nakajo (ORCID: https://orcid.org/0000-0002-7138-9848)
- Tomonori Yano (ORCID: https://orcid.org/0000-0002-0160-432X)
- Shingo Sakashita (ORCID: https://orcid.org/0000-0003-1133-3313)
- Hironori Sunakawa (ORCID: https://orcid.org/0000-0003-0792-9560)
- Atsushi Inaba (ORCID: https://orcid.org/0000-0001-7036-9485)
- Kensuke Shinmura (ORCID: https://orcid.org/0000-0001-8786-4634)
- Tomohiro Kadota (ORCID: https://orcid.org/0000-0002-0408-3494)
- Nobuhisa Minakata (ORCID: https://orcid.org/0000-0003-4540-4036)
- Yusuke Yoda (ORCID: https://orcid.org/0000-0002-8488-4303)
- Kenji Takashima
Institutions
- Chiba Cancer Center (JP)
- Saitama Cancer Center (JP)
- National Cancer Center Hospital East (JP)
Publication Details
- Journal
- Diseases of the Esophagus
- Published
- 2024-10-07
- DOI
- https://doi.org/10.1093/dote/doae083
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00